SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RUZZA, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.468
AS - Asia 3.078
EU - Europa 1.742
SA - Sud America 539
AF - Africa 76
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.908
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.358
SG - Singapore 1.210
CN - Cina 695
IT - Italia 458
VN - Vietnam 433
BR - Brasile 404
DE - Germania 236
HK - Hong Kong 227
PL - Polonia 192
GB - Regno Unito 164
FI - Finlandia 141
UA - Ucraina 135
FR - Francia 124
TR - Turchia 103
JP - Giappone 83
RU - Federazione Russa 80
IN - India 71
CA - Canada 59
AR - Argentina 56
BD - Bangladesh 55
ID - Indonesia 53
SE - Svezia 51
MX - Messico 32
NL - Olanda 29
ZA - Sudafrica 29
IQ - Iraq 25
PK - Pakistan 25
EC - Ecuador 20
ES - Italia 20
IE - Irlanda 19
BE - Belgio 18
AT - Austria 15
UZ - Uzbekistan 15
VE - Venezuela 15
CZ - Repubblica Ceca 14
CO - Colombia 13
LT - Lituania 13
AE - Emirati Arabi Uniti 11
KE - Kenya 10
TN - Tunisia 10
PH - Filippine 9
SA - Arabia Saudita 9
PE - Perù 7
PY - Paraguay 7
UY - Uruguay 7
CH - Svizzera 6
KR - Corea 6
MY - Malesia 6
NP - Nepal 6
AZ - Azerbaigian 5
CL - Cile 5
DZ - Algeria 5
KZ - Kazakistan 5
MA - Marocco 5
AL - Albania 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
RO - Romania 4
BO - Bolivia 3
DK - Danimarca 3
IL - Israele 3
KW - Kuwait 3
NG - Nigeria 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AU - Australia 2
BB - Barbados 2
CR - Costa Rica 2
GY - Guiana 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
TH - Thailandia 2
ZW - Zimbabwe 2
BJ - Benin 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
Totale 10.904
Salva come PNG Salva come JPEG
Città #
Ashburn 894
Singapore 756
Fairfield 498
San Jose 414
Woodbridge 401
Santa Clara 267
Beijing 248
Houston 238
Seattle 218
Hong Kong 215
Cambridge 194
Warsaw 186
Ann Arbor 183
Wilmington 183
Chandler 161
Ferrara 155
Jacksonville 154
Ho Chi Minh City 148
Los Angeles 110
New York 96
Hanoi 92
Munich 87
Tokyo 76
Helsinki 71
Shanghai 68
Lauterbourg 65
Dallas 63
Milan 58
Princeton 57
Council Bluffs 54
Izmir 53
Nanjing 44
Bologna 43
São Paulo 40
Jakarta 38
London 38
San Diego 33
Dearborn 31
Orem 31
Chicago 30
Da Nang 28
Turku 28
Boardman 27
Atlanta 26
Frankfurt am Main 25
Brooklyn 21
Mexico City 19
Dublin 18
Montreal 18
Brussels 17
Denver 17
Toronto 17
Belo Horizonte 16
Chennai 16
Falkenstein 16
Johannesburg 16
Lappeenranta 16
Rio de Janeiro 16
Addison 15
Buffalo 15
Moscow 14
Nanchang 14
Stockholm 14
Tashkent 14
Hefei 13
Phoenix 13
Shenyang 13
Tianjin 13
Assago 12
Brasília 12
Falls Church 12
Guangzhou 12
Norwalk 12
The Dalles 12
Haiphong 11
Manchester 11
Padova 11
San Francisco 11
Biên Hòa 10
Lahore 10
Nairobi 10
Vienna 10
Bremen 9
Dhaka 9
Mumbai 9
Poplar 9
Washington 9
Baghdad 8
Hải Dương 8
Nuremberg 8
Porto Alegre 8
Redwood City 8
Amsterdam 7
Ankara 7
Boston 7
Changsha 7
Guayaquil 7
Hebei 7
New Delhi 7
Olomouc 7
Totale 7.583
Salva come PNG Salva come JPEG
Nome #
Pharmacological and neurobiological studies on Neuropeptide S and its receptor 267
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 251
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 242
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 239
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 237
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 234
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 233
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 222
Modulation of the NOP receptor signaling affects resilience to acute stress 220
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 216
Pharmacological characterization of tachykinin tetrabranched derivatives 212
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 211
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 206
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 204
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 204
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 203
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 200
Neuropeptide S receptor ligands: a patent review (2005-2016) 199
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 196
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 196
Structure-activity study at positions 3 and 4 of human neuropeptide S. 194
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 193
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 190
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 189
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 188
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 185
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 178
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 176
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 171
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence 162
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 162
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 160
Novel Mixed NOP/Opioid Receptor Peptide Agonists 157
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine 148
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 148
Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test 140
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 138
The concise guide to pharmacology 2021/22: G protein-coupled receptors 137
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders 136
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors 134
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 129
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 129
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics 127
NOP Ligands for the Treatment of Anxiety and Mood Disorders 125
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice 122
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress 118
Pharmacological characterization of naloxegol: In vitro and in vivo studies 112
Preclinical effects of cannabidiol in an experimental model of migraine 110
Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis 110
null 110
Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling 109
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus 107
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test 107
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 107
null 105
The concise guide to pharmacology 2019/20: G protein-coupled receptors 103
Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice 101
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo 98
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 94
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors 94
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 94
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 93
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 91
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay 91
Effects of Stress Exposure to Pain Perception in Pre-Clinical Studies: Focus on the Nociceptin/Orphanin FQ-NOP Receptor System 90
Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study 87
null 87
Pharmacology, physiology and genetics of the neuropeptide s system 80
null 77
Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice 76
Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress 66
Nociceptin/OrphaninFQ Receptor Modulates the Maturation of Adult-Born Neurons in the Mouse Dentate Gyrus Under Physiological Conditions and in a Chronic Stress Model 62
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 59
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and Mitophagy 49
null 42
The concise guide to pharmacology 2017/18: Overview 39
Totale 11.078
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 759
Totale 51.237
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 0 0 0 0 0 0 0 0 0 102 74 49
2021/2022524 33 35 28 39 37 38 27 41 24 52 35 135
2022/2023455 58 42 23 48 58 44 39 37 50 5 27 24
2023/2024427 32 47 25 14 26 78 22 39 4 21 14 105
2024/20251.682 43 43 153 73 191 177 16 73 293 169 238 213
2025/20265.036 562 274 407 619 806 348 663 331 504 522 0 0
Totale 11.078